Skip to main
LDOS
LDOS logo

Leidos Hld (LDOS) Stock Forecast & Price Target

Leidos Hld (LDOS) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 27%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Leidos Holdings Inc has exhibited significant improvement in its Health & Civil segment, with EBIT margins rising from 14.5% in 2023 to 22.5% in 2024, and reaching an impressive 24.3% in the first half of 2025, driven by increased exam volumes and completed claims. The company's growth is supported by strategic initiatives from the Department of Veterans Affairs aimed at reducing the claims backlog to 60,000 by the end of 2025, which is expected to bolster near-term volume strength. Overall, the company's operational scale advancements and enhancing margins indicate a positive outlook for future performance.

Bears say

Leidos Holdings Inc. faces a negative outlook primarily due to projected margin declines in the second half of 2025 compared to the first half, indicating a potential contraction in profitability. Additionally, there are significant risks associated with the budget environment, which could further undermine investor sentiment if margins deteriorate markedly. A crucial factor contributing to this outlook is the anticipated decrease in medical exam volumes, which may exert additional pressure on margins within the company's health services segment.

Leidos Hld (LDOS) has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 27% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Leidos Hld (LDOS) Forecast

Analysts have given Leidos Hld (LDOS) a Buy based on their latest research and market trends.

According to 11 analysts, Leidos Hld (LDOS) has a Buy consensus rating as of Nov 6, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $197.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $197.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Leidos Hld (LDOS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.